Pacific Biosciences of California, Inc. ( NASDAQ: PACB) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Todd Friedman - Senior Director, Finance and Investor Relations Christian Henry - ...
Hosted on MSN11mon
PacBio's (PACB) New Panel to Aid Its Clinical Research SolutionThe recently released Nanobind PanDNA kit is used in the PureTarget Repeat Expansion Panel procedure, which guarantees reliable outcomes tailored for Revio and Sequel IIe customers. On the PacBio ...
This collaboration builds off the earlier success of the 2019 agreement between the two companies whereby Berry Genomics supported the regulatory authorization of the PacBio Sequel II instrument ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback